サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1606391

動物用腫瘍学市場：治療タイプ別、動物タイプ別、がんタイプ別、製品タイプ別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年

Veterinary Oncology Market, By Therapy Type, By Animal Type, By Cancer Type, By Product Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 301 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.35円
動物用腫瘍学市場：治療タイプ別、動物タイプ別、がんタイプ別、製品タイプ別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年
出版日: 2024年11月04日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

動物用腫瘍学市場規模は2023年に11億832万米ドルとなり、2024年から2032年にかけてCAGR 11.30%で拡大

動物用腫瘍学市場 - 市場力学

ペット飼育と支出の増加が動物用腫瘍学市場のニーズを促進

ペット飼育の増加傾向とペットヘルスケアへの支出の増加が、動物用腫瘍学市場の著しい成長を促進しています。ペットが家族の一員とみなされるようになったことで、飼い主はペットの健康を守るため、がん治療を含む先進医療への投資をより厭わなくなった。このような意識の変化は、可処分所得の増加に支えられ、動物用腫瘍学サービスに対する需要の増加をもたらしています。さらに、ペットのがんに対する認識の高まりと専門的な治療法の利用可能性が市場拡大にさらに寄与しており、この分野における継続的な進歩の重要な必要性が浮き彫りになっています。

動物用腫瘍学市場 - 主な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024年～2032年）に約11.30%のCAGRで毎年成長すると推定されます。

動物タイプ別では、畜産動物が2023年に最大の市場シェアを示すと予測されています。

治療タイプ別では、化学療法が2023年の主要タイプでした。

エンドユーザー別では、動物病院が2023年に主要なタイプでした。

地域別では、アジア太平洋地域が2023年の売上高でトップでした。

動物用腫瘍学市場 - セグメンテーション分析：

世界の動物用腫瘍学市場は、治療タイプ、動物タイプ、がんタイプ、動物タイプ、エンドユーザー、地域に基づいてセグメント化されます。

市場は動物タイプに基づいて、コンパニオンアニマルと畜産動物の2つのカテゴリーに分けられます。動物福祉の重要性に対する認識は高まっており、それはがんを含む疾病管理にも及んでいます。農家や家畜の所有者は、動物のヘルスケア向上に投資しており、腫瘍学サービスの需要を促進しています。牛、鶏、豚などの畜産動物は世界経済にとって不可欠であり、肉、乳製品、卵などの食品を提供しています。がん治療を含む家畜の健康確保は、経済的損失を防ぐ上で極めて重要です。

市場はエンドユーザーによって、動物病院、動物診療所、研究機関、学術機関の4つのカテゴリーに分けられます。動物用腫瘍学市場における動物病院の市場シェアが高いのは、いくつかの要因によるものです。動物病院はさまざまな動物のプライマリーケアセンターとして、化学療法、放射線療法、外科手術などの専門的ながん治療を提供しています。これらの施設は、高度な診断ツール、特殊な機器、熟練した獣医腫瘍医を利用できることが多く、がんを患うペットのケアの質を高めています。

動物用腫瘍学市場 - 地理的洞察

アジア太平洋地域の動物用腫瘍学市場は、ペットの飼育数の増加、動物の健康に対する意識の高まり、獣医診断および治療の進歩に牽引され、著しい成長を遂げています。中国、日本、インドのような国々は、ペット人口の増加と高度な獣医学的診療の採用により、市場拡大に大きく貢献しています。日本は特に洗練された動物医療インフラで知られ、中国とインドはペットの腫瘍学サービスの需要が急速に伸びています。動物におけるがんの有病率の増加は、獣医専門クリニックの進展と治療の選択肢の拡大と相まって、この地域の市場をさらに押し上げています。

動物用腫瘍学市場 - 競合情勢：

動物用腫瘍市場の競合情勢は、動物用がんの診断薬、治療薬、高度な治療ソリューションを提供する主要企業によって特徴づけられます。Zoetis Inc.、Elanco Animal Health、Merck Animal Healthのような企業が最前線にあり、広範な研究能力と製品ポートフォリオを活用してペットの様々ながんに対処しています。これらのマーケットリーダーは、標的治療や免疫療法などの革新的治療に注力しています。加えて、VetDCやABサイエンスのような中小企業や専門企業も、新規化学療法やキナーゼ阻害剤のようなニッチ製品で牽引役となっています。共同研究、戦略的買収、提携は一般的であり、これによって企業は技術的能力を拡大し、事業範囲を広げることができます。より効果的で安全な治療法に対する需要の高まりと、ペットの飼育と獣医療の増加が、この市場の競争を引き続き促進しています。

目次

第1章 動物用腫瘍学市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 動物用腫瘍学の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 動物用腫瘍学産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 動物用腫瘍学市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 動物用腫瘍学市場情勢

  • 動物用腫瘍学市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 動物用腫瘍学市場 - 治療タイプ別

  • 概要
    • 治療タイプ別のセグメントシェア分析
    • 化学療法
    • 放射線治療
    • 免疫療法
    • 手術
    • 標的療法
    • 併用療法

第8章 動物用腫瘍学市場 - 動物タイプ別

  • 概要
    • 動物タイプ別のセグメントシェア分析
    • ペット
      • 犬
      • 猫
    • 家畜
      • 馬
      • 牛
      • その他

第9章 動物用腫瘍学市場 - がんタイプ別

  • 概要
    • がんタイプ別のセグメントシェア分析
    • リンパ腫
    • 肥満細胞がん
    • 乳腺と乳がん
    • 悪性黒色腫
    • 骨肉腫（骨がん）
    • 血管肉腫
    • その他の腫瘍（例：皮膚、口腔など）

第10章 動物用腫瘍学市場 - 製品タイプ別

  • 概要
    • 製品タイプ別のセグメントシェア分析
    • 薬物
      • 化学療法剤
      • 標的薬
      • 免疫療法剤
    • デバイス
      • 放射線治療装置
      • 画像診断装置（MRI、CTスキャナ等）
      • 手術器具

第11章 動物用腫瘍学市場 - エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 動物病院
    • 動物診療所
    • 研究機関
    • 学術機関

第12章 動物用腫瘍学市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第13章 主要ベンダー分析 - 動物用腫瘍学業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Zoetis Inc.
    • Boehringer Ingelheim Animal Health
    • Elanco Animal Health
    • Merck Animal Health（a division of Merck &Co., Inc.）
    • AB Science
    • Aratana Therapeutics
    • Regeneus Ltd
    • Varian Medical Systems
    • VetDC
    • Karyopharm Therapeutics
    • Others

第14章 アナリストの全方位展望

目次
Product Code: ANV4219

REPORT HIGHLIGHT

Veterinary Oncology Market size was valued at USD 1,108.32 million in 2023, expanding at a CAGR of 11.30% from 2024 to 2032.

The veterinary oncology market focuses on the diagnosis and treatment of cancer in animals, primarily companion animals like dogs and cats. It includes various services and products such as chemotherapy, immunotherapy, radiation therapy, and surgery. The rising pet ownership, growing awareness of animal health, and advancements in veterinary care have driven the market's growth. Additionally, the increasing incidence of cancer in pets and the availability of advanced diagnostic tools contribute to market expansion. The sector is supported by veterinary pharmaceutical companies and specialized clinics, with innovations in targeted therapies and personalized treatments enhancing the market's potential.

Veterinary Oncology Market- Market Dynamics

Increasing Pet Ownership and Spending Drives the Need for the Veterinary Oncology Market

The rising trend of pet ownership and increased spending on pet healthcare is driving significant growth in the veterinary oncology market. As pets are increasingly considered part of the family, pet owners are more willing to invest in advanced medical treatments, including cancer therapies, to ensure their pets' well-being. This shift in attitude, supported by higher disposable incomes, has resulted in greater demand for veterinary oncology services. Additionally, the growing awareness of pet cancers and the availability of specialized treatments have further contributed to market expansion, highlighting the crucial need for continued advancements in this field.

Veterinary Oncology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.30% over the forecast period (2024-2032)

Based on animal type segmentation, Livestock Animals was predicted to show maximum market share in the year 2023

Based on therapy type segmentation, Chemotherapy was the leading type in 2023

Based on end-user segmentation, Veterinary Hospitals was the leading type in 2023

Based on region, Asia Pacific was the leading revenue generator in 2023

Veterinary Oncology Market- Segmentation Analysis:

The Global Veterinary Oncology Market is segmented based on Therapy Type, Animal Type, Cancer Type, Animal Type, End User, and Region.

The market is divided into two categories based on animal type: Companion Animals, and Livestock Animals. There is increasing awareness about the importance of animal welfare, which extends to disease management, including cancer. Farmers and livestock owners are investing in better healthcare for their animals, driving demand for oncology services. Livestock animals, such as cattle, poultry, and swine, are vital to the global economy, providing food products like meat, dairy, and eggs. Ensuring their health, including cancer treatment, is critical to preventing economic losses.

The market is divided into four categories based on end users: Veterinary Hospitals, Veterinary Clinics, Research Institutes, and Academic Institutions. The high market share of veterinary hospitals in the veterinary oncology market can be attributed to several factors. Veterinary hospitals serve as primary care centers for a wide range of animals, offering specialized cancer treatments such as chemotherapy, radiation therapy, and surgery. These facilities often have access to advanced diagnostic tools, specialized equipment, and skilled veterinary oncologists, which enhances the quality of care for pets with cancer.

Veterinary Oncology Market- Geographical Insights

The veterinary oncology market in the Asia Pacific region is experiencing notable growth, driven by rising pet ownership, increasing awareness about animal health, and advancements in veterinary diagnostics and treatments. Countries like China, Japan, and India are key contributors to market expansion due to their growing pet populations and the adoption of advanced veterinary practices. Japan is particularly known for its sophisticated veterinary healthcare infrastructure, while China and India are witnessing rapid growth in demand for oncology services for pets. The increasing prevalence of cancer in animals, combined with the development of veterinary specialty clinics and an expanding range of treatment options, further propels the market in this region.

Veterinary Oncology Market- Competitive Landscape:

The competitive landscape of the veterinary oncology market is marked by key players offering a range of diagnostics, therapeutics, and advanced treatment solutions for animal cancers. Companies like Zoetis Inc., Elanco Animal Health, and Merck Animal Health are at the forefront, leveraging their extensive research capabilities and product portfolios to address various forms of cancer in pets. These market leaders focus on innovative therapies such as targeted treatments and immunotherapies. In addition, smaller companies and specialized firms, such as VetDC and AB Science, are also gaining traction with niche products like novel chemotherapies and kinase inhibitors. Collaborations, strategic acquisitions, and partnerships are common, allowing players to expand their technological capabilities and reach. The growing demand for more effective and safer treatments and increased pet ownership and veterinary care continue to drive competition in this market.

Recent Developments:

In August 2024, Akston Biosciences Corporation, which is dedicated to accelerating the biologics revolution in Animal Health, and Purdue University announced a strategic partnership to co-develop an anti-cPD-L1 monoclonal antibody (mAb) immunotherapy to treat cancer in dogs.

In September 2024, CureLab Veterinary Inc, a biopharmaceutical company that develops cancer treatments for pets, announced a Regulation D fundraising offer to develop its gene therapy, ElenaVet, which enhances the body's anticancer immune response and reduces chronic inflammation. The offering is being carried out in compliance with Rule 506(c) of Regulation D, which was issued under the amended Securities Act of 1933.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VETERINARY ONCOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Zoetis Inc.
  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health
  • Merck Animal Health (a division of Merck & Co., Inc.)
  • AB Science
  • Aratana Therapeutics
  • Regeneus Ltd
  • Varian Medical Systems
  • VetDC
  • Karyopharm Therapeutics
  • Others

GLOBAL VETERINARY ONCOLOGY MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Chemotherapy
  • Radiation Therapy
  • Immunotherapy
  • Surgery
  • Targeted Therapy
  • Combination Therapy

GLOBAL VETERINARY ONCOLOGY MARKET, BY ANIMAL TYPE - MARKET ANALYSIS, 2019 - 2032

  • Companion Animals
  • Dogs
  • Cats
  • Livestock Animals
  • Horses
  • Cattle
  • Others

GLOBAL VETERINARY ONCOLOGY MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2019 - 2032

  • Lymphoma
  • Mast Cell Cancer
  • Mammary and Breast Cancer
  • Melanoma
  • Bone Cancer (Osteosarcoma)
  • Hemangiosarcoma
  • Other Tumors (e.g., Skin, Oral, etc.)

GLOBAL VETERINARY ONCOLOGY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Drugs
  • Chemotherapeutic Agents
  • Targeted Drugs
  • Immunotherapy Agents
  • Devices
  • Radiation Therapy Equipment
  • Imaging Devices (MRI, CT Scanners, etc.)
  • Surgical Instruments

GLOBAL VETERINARY ONCOLOGY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Veterinary Hospitals
  • Veterinary Clinics
  • Research Institutes
  • Academic Institutions

GLOBAL VETERINARY ONCOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Veterinary Oncology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Veterinary Oncology Market Snippet by Therapy Type
    • 2.1.2. Veterinary Oncology Market Snippet by Animal Type
    • 2.1.3. Veterinary Oncology Market Snippet by Cancer Type
    • 2.1.4. Veterinary Oncology Market Snippet by Product Type
    • 2.1.5. Veterinary Oncology Market Snippet by End User
    • 2.1.6. Veterinary Oncology Market Snippet by Country
    • 2.1.7. Veterinary Oncology Market Snippet by Region
  • 2.2. Competitive Insights

3. Veterinary Oncology Key Market Trends

  • 3.1. Veterinary Oncology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Veterinary Oncology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Veterinary Oncology Market Opportunities
  • 3.4. Veterinary Oncology Market Future Trends

4. Veterinary Oncology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Veterinary Oncology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Veterinary Oncology Market Landscape

  • 6.1. Veterinary Oncology Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Veterinary Oncology Market - By Therapy Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therapy Type, 2023 & 2032 (%)
    • 7.1.2. Chemotherapy
    • 7.1.3. Radiation Therapy
    • 7.1.4. Immunotherapy
    • 7.1.5. Surgery
    • 7.1.6. Targeted Therapy
    • 7.1.7. Combination Therapy

8. Veterinary Oncology Market - By Animal Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Animal Type, 2023 & 2032 (%)
    • 8.1.2. Companion Animals
      • 8.1.2.1. Dogs
      • 8.1.2.2. Cats
    • 8.1.3. Livestock Animals
      • 8.1.3.1. Horses
      • 8.1.3.2. Cattle
      • 8.1.3.3. Others

9. Veterinary Oncology Market - By Cancer Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Cancer Type, 2023 & 2032 (%)
    • 9.1.2. Lymphoma
    • 9.1.3. Mast Cell Cancer
    • 9.1.4. Mammary and Breast Cancer
    • 9.1.5. Melanoma
    • 9.1.6. Bone Cancer (Osteosarcoma)
    • 9.1.7. Hemangiosarcoma
    • 9.1.8. Other Tumors (e.g., Skin, Oral, etc.)

10. Veterinary Oncology Market - By Product Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Animal Type, 2023 & 2032 (%)
    • 10.1.2. Drugs
      • 10.1.2.1. Chemotherapeutic Agents
      • 10.1.2.2. Targeted Drugs
      • 10.1.2.3. Immunotherapy Agents
    • 10.1.3. Devices
      • 10.1.3.1. Radiation Therapy Equipment
      • 10.1.3.2. Imaging Devices (MRI, CT Scanners, etc.)
      • 10.1.3.3. Surgical Instruments

11. Veterinary Oncology Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2. Veterinary Hospitals
    • 11.1.3. Veterinary Clinics
    • 11.1.4. Research Institutes
    • 11.1.5. Academic Institutions

12. Veterinary Oncology Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Veterinary Oncology Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Veterinary Oncology Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Veterinary Oncology Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Veterinary Oncology Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Veterinary Oncology Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Veterinary Oncology Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. Zoetis Inc.
    • 13.2.2. Boehringer Ingelheim Animal Health
    • 13.2.3. Elanco Animal Health
    • 13.2.4. Merck Animal Health (a division of Merck & Co., Inc.)
    • 13.2.5. AB Science
    • 13.2.6. Aratana Therapeutics
    • 13.2.7. Regeneus Ltd
    • 13.2.8. Varian Medical Systems
    • 13.2.9. VetDC
    • 13.2.10. Karyopharm Therapeutics
    • 13.2.11. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us